All In MedTech

Device Trial Radar · NCT02408458

Miromatrix Biological Mesh for Ventral Hernia Repair

A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair

Last checked: Nov 19, 2026Latest source record: Oct 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jun 2015

Primary completion

Apr 2016

Study completion Apr 2016

Sponsor

Lead sponsor
Miromatrix Medical Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 3, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to gather long-term data of the performance of the Miromatrix Biological Mesh.

Conditions

  • Ventral Hernia

Interventions

  • MIROMESH®Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hernia recurrence requiring surgical interventionTime frame: 1 year

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Sarasota Memorial Hospital

    Sarasota, Florida

  • University of Kentucky

    Lexington, Kentucky

  • Penn State Hershey Medical Center

    Hershey, Pennsylvania

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.